Page last updated: 2024-11-02

pindolol and Anankastic Personality

pindolol has been researched along with Anankastic Personality in 6 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blier, P1
Bergeron, R1
Koran, LM1
Mueller, K1
Maloney, A1
Mundo, E1
Guglielmo, E1
Bellodi, L1
Goodman, WK1
Dannon, PN1
Sasson, Y1
Hirschmann, S1
Iancu, I1
Grunhaus, LJ1
Zohar, J1
Koch, HJ1
Raschka, C1
Hannak, D1

Reviews

1 review available for pindolol and Anankastic Personality

ArticleYear
Obsessive-compulsive disorder: diagnosis and treatment.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 18

    Topics: Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Comorbidit

1999

Trials

3 trials available for pindolol and Anankastic Personality

ArticleYear
Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
    International clinical psychopharmacology, 1998, Volume: 13, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Comb

1998
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Femal

2000
Pindolol can be effectively given once or twice daily for augmentation in psychiatric patients.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:6

    Topics: Cross-Over Studies; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Patient Compliance;

2000

Other Studies

2 other studies available for pindolol and Anankastic Personality

ArticleYear
Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings.
    International clinical psychopharmacology, 1996, Volume: 11, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Buspirone; Depression; Drug Resistance; Drug Therapy, Combinatio

1996
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3

    Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Syner

1996